Digital Health & Innovation

The Data Era Is Shifting to the Decision-Making Era: What This Means for Pharma Marketing

For more than two decades, the pharmaceutical industry has invested heavily in collecting, organizing, and analyzing scientific and commercial data. From clinical trial registries to real-world evidence platforms, Pharma has built vast repositories of information.1 But scale is no longer the differentiator.   As healthcare grows more complex, regulatory scrutiny intensifies, and therapeutic innovation accelerates, […]

   

AI That Can’t Forget: How Memory Limits Affect AI Responses

Many of us have experienced something like this. You use an AI system to help prepare a strategic project for the launch of a new medication. At the beginning of the conversation, you provide the following information: “The newly approved indication is for patients at high cardiovascular risk.” Later, you update it: “Actually, the recommendation […]

   

How Does Cancer Evade the Immune System?

Understanding cancer requires viewing it as a systemic disease, focusing not only on the malignant cells but also on the patient and the microenvironment in which the tumor develops.1    Primary and metastatic tumors are complex ecosystems composed of neoplastic cells, extracellular matrix, and “accessory” non-neoplastic cells, which include cells important for the tumor’s structure […]

   

Trends in Health Communication: Insights for Modern Pharma Marketing

Scientific communication is undergoing constant transformation—and professionals in pharmaceutical and healthcare marketing need to evolve with it. Staying ahead means adopting more engaging language, embracing innovative tools, and continuously measuring impact.1  Even before the COVID-19 pandemic, healthcare professionals and patients were already changing how they accessed and consumed information. The pandemic accelerated this shift, driving […]